14/09/2020 Cassava Sciences announces positive results of its Phase IIb trial of sumifilam in AD Science watch
01/09/2020 Cortexyme reaches milestone with 500 research participants enrolled in its GAIN Phase II/III trial of COR388 in mild to moderate AD Science watch
31/08/2020 Axsome Therapeutics announces development status for AXS-05 in the treatment of AD agitation Science watch
18/08/2020 Study looks at person‐centred approach to implementation of psychosocial interventions for people with an intellectual disability and dementia Science watch
07/08/2020 FDA accepts Biogen’s aducanumab license application for AD with priority review Science watch
04/08/2020 Incidence rate of dementia in Europe and North America declined by 13% per decade between 1988 and 2015, study shows Science watch
30/07/2020 New research suggests that early-life health factors may influence Alzheimer’s dementia risk Science watch
30/07/2020 Lancet Commission on dementia prevention, intervention and care identifies 12 modifiable risk factors accounting for 40% of dementias Science watch
28/07/2020 Clinical study confirms the diagnostic accuracy of blood test for p-tau217 biomarker in AD Science watch
27/07/2020 The IDEAS study reports that amyloid PET scans had a small impact on rates of hospitalisations and fails to meet its pre-specified endpoint Science watch
